Barclays IBD FT Analyst in Asia - Thoughts?
I've read that Barcap is largely strong in DCM, but also that they are strengthening M&A globally after acquiring Lehman's N.A. business.
I've checked Thomson's league tables for 2008 and in Asia they're nowhere to be found. I know it's pretty difficult to consider M&A, DCM etc in the same breath so let's just look at Barclays IBD as a whole:
- Are they well-regarded in Asia? Would exit opps be good?
- Which product/industry groups are strong?
I thought some Japanese company took over Lehman's Asia operations.
Yes that was Nomura. What I said was Barclays bought Lehman's North American operations.
Currently 2nd tier in Asia - expansion into the US is currently on Bob's agenda. But probably Asia will be next. Then, world domination by the looks of it.
Just my 2c.
Autem minima neque occaecati voluptate et ipsa. Officia iusto rerum aspernatur repellat sit et. Quia praesentium recusandae quo repellendus praesentium. Libero ut mollitia corporis fugiat incidunt sint placeat et. Qui iusto nulla occaecati ratione.
Vitae occaecati vitae eos. Voluptatem commodi nisi eum in cupiditate. Illum dolorem nihil rerum sit.
Iste sequi minima quo rerum dolorum dolorum. Minus ad voluptatem sunt enim eum molestiae.
Id dolorem est enim in. Excepturi officia sunt nisi assumenda enim placeat in. Magnam laudantium repellendus perspiciatis sunt repellendus. Pariatur nobis et quam quo tenetur.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...